Peer-Reviewed Journal Details
Mandatory Fields
Gordon M.;Dinnett E.;Ronald E.;Gaw A.;Cobbe S.;Macfarlane P.;Stott D.;Mungall M.;Shepherd J.;Ford I.;Norrie J.;Packard C.;Meinders A.;Jukema J.;Blauw G.;Bollen E.;Kamper A.;Westendorp R.;Twomey C.;Murphy M.;Buckley B.;Hyland M.;Perry I.
2006
October
Good Clinical Practice Journal
Evaluating endpoints
Validated
Scopus: 1 ()
Optional Fields
Clinical event monitors Endpoint adjudication committee The PROSPER study
13
10
25
29
Endpoint analysis and validation is an aspect of trial design that prompts much discussion. Members of the PROSPER study team share their experiences of choosing appropriate endpoints for a large cardiovascular trial, and how they ensured consistency in endpoint decision-making. Informa UK Ltd.
1350-0961
Grant Details